(UroToday.com) In the World Urological Oncology Federation (WUOF) Symposium held in conjunction with this year’s virtual Société Internationale d’Urologie (SIU) annual congress, Dr. Robert Kerbel discussed a preclinical approach to predict treatment outcomes.
(UroToday.com) In the Plenary 03 session of this year’s virtual Société Internationale d’Urologie (SIU) annual congress, Dr. Robert Hamilton presented the Canadian Urological Association Lecture examining the current and future state of robotics in urologic oncology.
(UroToday.com) At the 2020 Société Internationale d’Urologie (SIU) virtual annual meeting Dr. Peter Black hosted a multidisciplinary session assessing the management of early-stage bladder cancer with thought leaders including Dr. Jurgen E. Gschwend, Dr. Shilpa Gupta, Dr. Srikala Sridhar, and Dr. Tilman Todenhofer.
(UroToday.com) In the Joint SIU-Korean Urological Association (KUA) Symposium at this year’s virtual Société Internationale d’Urologie (SIU) 2020 Virtual Annual Congress, Dr. Kim provided an update on the management of non-metastatic castration-resistant prostate cancer (nmCRPC).
(UroToday.com) In the Joint SIU-Korean Urological Association (KUA) Symposium at this year’s virtual SIU annual congress, Dr. Paolo Gontero presented on the role of ureteroscopy prior to radical nephroureterectomy. He began by highlighting the different management approaches for patients with high- and low-risk upper tract urothelial carcinoma, namely, radical nephroureterectomy and kidney sparing surgery, respectively. He […]
(UroToday.com) At the Société Internationale d’Urologie (SIU) 2020 Virtual Annual Congress’ debate on the management of oligometastatic prostate cancer, Dr. Noel Clarke argued that metastases should be treated with systemic therapy alone. Dr. Clarke started by noting that there are several definitions for “metastasis”. According to Wikipedia, metastasis is a pathogenic agent’s spread from an initial […]
(UroToday.com) At the Société Internationale d’Urologie (SIU) 2020 Virtual Annual Congress’ debate on the management of oligometastatic prostate cancer, Dr. Patrick Cheung argued that metastases should be treated with metastasis-directed therapy. Dr. Cheung is the study co-chair on the Canadian PLATON trial, which is a randomized Phase III trial of local ablative therapy or not for […]
(UroToday.com) The Société Internationale d’Urologie (SIU) 2020 Virtual Annual Congress featured a debate discussing imaging definitions for oligometastatic prostate cancer. Dr. Renu Eapen from Australia argued that oligometastatic disease should be defined based on novel imaging modalities. Based on population-level data from Australia, Dr. Eapen notes that there is an increasing proportion of patients undergoing radical […]
(UroToday.com) The Société Internationale d’Urologie (SIU) 2020 Virtual Annual Congress featured a debate discussing imaging definitions for oligometastatic prostate cancer. Dr. Noel Clarke from the United Kingdom argued that oligometastatic disease should be defined based on standard imaging modalities. Dr. Clarke started by presenting a case of a 69-year-old man with cT3 M0 prostate cancer, a […]
Dr. Alvaro Aytes (Barcelona, ES) was finishing his postdoc in the United States when he started exploring funding opportunities for a new research project. “I was an associate research scientist at Columbia University in New York, and after seven years I wasn’t that well connected to European funding opportunities anymore. I think it was through […]
